Literature DB >> 2938703

Prolonged neuromuscular blockade with atracurium.

M D Bizzarri-Schmid, S P Desai.   

Abstract

During general anaesthesia with oxygen, nitrous oxide and enflurane, a 29-year-old woman received a total of 105 mg (1.78 mg X k-1) of atracurium over a 2.5 hour period. The neuromuscular blockade could not be completely reversed with neostigmine and mechanical ventilatory support was necessary for three hours postoperatively. The patient received succinylcholine without unusual sequelae before and after this episode. This is the first report of a patient who exhibited prolonged weakness after receiving atracurium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938703     DOI: 10.1007/bf03010832

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  15 in total

Review 1.  Drug therapy: Disorders of neuromuscular transmission caused by drugs.

Authors:  Z Argov; F L Mastaglia
Journal:  N Engl J Med       Date:  1979-08-23       Impact factor: 91.245

2.  The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block.

Authors:  B E Waud; D R Waud
Journal:  Anesthesiology       Date:  1971-11       Impact factor: 7.892

3.  Sensitivity to nondepolarizing muscle relaxants in amyotrophic lateral sclerosis: report of two cases.

Authors:  K J Rosenbaum; J L Neigh; G E Strobel
Journal:  Anesthesiology       Date:  1971-12       Impact factor: 7.892

Review 4.  The choice and mode of administration of relaxants. 5. Patients with altered sensitivity.

Authors:  E N Cohen
Journal:  Clin Anesth       Date:  1966

5.  Myotonia and neuromuscular blocking agents.

Authors:  M M Mitchell; H H Ali; J J Savarese
Journal:  Anesthesiology       Date:  1978-07       Impact factor: 7.892

6.  Evaluation of atracurium in anaesthetized man.

Authors:  J P Payne; R Hughes
Journal:  Br J Anaesth       Date:  1981-01       Impact factor: 9.166

7.  The pharmacology of atracurium: a new competitive neuromuscular blocking agent.

Authors:  R Hughes; D J Chapple
Journal:  Br J Anaesth       Date:  1981-01       Impact factor: 9.166

8.  Pharmacokinetics and pharmacodynamics of d-tubocurarine during hypothermia in the cat.

Authors:  J Ham; R D Miller; L Z Benet; R S Matteo; L L Roderick
Journal:  Anesthesiology       Date:  1978-11       Impact factor: 7.892

Review 9.  Characteristics and mechanism of neuromuscular block in myasthenia gravis.

Authors:  D Grob; T Namba
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

10.  Safety and efficacy of atracurium (BW33A) in surgical patients receiving balanced or isoflurane anesthesia.

Authors:  M D Sokoll; S D Gergis; M Mehta; N M Ali; C Lineberry
Journal:  Anesthesiology       Date:  1983-05       Impact factor: 7.892

View more
  5 in total

1.  Full-cost determination of different levels of care in the intensive care unit. An activity-based costing approach.

Authors:  J J Doyle; J P Casciano; S R Arikian; J Mauskopf; J E Paul
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

2.  Antiestrogenic drugs and atracurium--a possible interaction?

Authors:  M Naguib; H K Gyasi
Journal:  Can Anaesth Soc J       Date:  1986-09

3.  Prolonged neuromuscular blockade with atracurium.

Authors:  F Donati
Journal:  Can Anaesth Soc J       Date:  1986-09

4.  Prolonged neuromuscular blockade and ventilatory failure after renal transplantation and cyclosporine.

Authors:  A Sidi; R F Kaplan; R F Davis
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

Review 5.  Approach to neuromuscular disorders in the intensive care unit.

Authors:  Kenneth C Gorson
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.